Evidence map›Paper›PMID 42205266›Full record

ArticleFrontiers in endocrinology2026

Association between single-point insulin sensitivity estimator and three-vessel coronary disease: a cross-sectional study.

Wei Yang, Gaoying Dai, Nanhu Quan, Qian Tong

Abstract read
In one paragraph

Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Wei YangDepartment of Cardiovascular Center, The First Hospital of Jilin University, Changchun, China.
Gaoying DaiDepartment of Cardiovascular Center, The First Hospital of Jilin University, Changchun, China.
Nanhu QuanDepartment of Cardiovascular Center, The First Hospital of Jilin University, Changchun, China.
Qian TongDepartment of Cardiovascular Center, The First Hospital of Jilin University, Changchun, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: The single-point insulin sensitivity estimator (SPISE) is a novel surrogate marker for assessing insulin resistance in humans. Three-vessel coronary disease (TVD) remains a major challenge in coronary interventional therapy. However, the association between the SPISE index and TVD remains unclear. Therefore, this study aimed to evaluate the relationship between SPISE and TVD in an elderly population. Methods: Generalized additive models (GAM) and random forest variable importance scores were applied for feature selection to identify key predictors for constructing a TVD risk model. Multivariable regression and restricted cubic spline (RCS) analyses were performed to investigate the association between SPISE and TVD. Subgroup analyses were further conducted to assess potential effect modification. Results: GAM and random forest variable importance scores identified age and SPISE as the most important predictors. After adjustment for all covariates, SPISE was inversely associated with TVD (OR = 0.75, 95% CI: 0.68-0.83, Conclusion: A higher SPISE index is independently and inversely associated with TVD and may serve as a reliable predictor of disease risk, highlighting its potential utility in cardiovascular risk assessment.

Indexed as

Coronary Artery DiseaseCoronary DiseaseInsulin ResistanceAgedBiomarkersCross-Sectional StudiesFemaleHumansMaleRisk FactorsROC CurveBiomarkerscross-sectional studyinsulin resistancesingle-point insulin sensitivity estimatorthree-vessel coronary diseasetriglyceride-glucose index

Identifiers

PMID42205266
PMCPMC13201101

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.